CCC(C)(C)NC(=O)C(c1cccc(OC)c1OC)N(CCC(C)C)C(=O)CCC(=O)Nc1cc(C)on1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?